Shoujiang Wei

Dr. Shoujiang Wei


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 February 2022 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
JHJinsong He
Jinsong He
JHJing Huang
Jing Huang
GTGuo Tang
Guo Tang
PWPan Wang
Pan Wang
MHMing He
Ming He
SWShoujiang Wei
Shoujiang Wei
Introduction: Zinc finger protein 154 (ZNF154) has been identified as a tumor suppressor gene in multiple carcinomas. Lymph node (LN) metastasis is one of the most intensively negative factor of gastric cancer (GC) prognosis. However, the potential mechanisms of ZNF154-mediated LN metastasis are not elucidated. This study aimed to investigate the role of ZNF154 in LN metastasis of GC and their underlying mechanisms through in vitro and in vivo experiments. Methods: Antitumor effect was measured by growth inhibition by cell counting kit-8 (CCK-8) and colony formation assay. Cell cycle distribution and apoptosis were evaluated by flow cytometry. Cell migration and invasion were measured by wound healing and transwell invasion assays, respectively. The expression levels of proteins were analyzed by Western blot. Xenograft models were used for validation in vivo. Results: Our research showed that ZNF154 was down-regulated in 81.43% (57 of 70) of GC tissues compared with 58.6% of paired non-tumor tissues from patients, ZNF154 was down-regulated in 100% (7 of 7) of GC cell lines, up-regulated expression of ZNF154 in MGC-803 GC cells reduced cell proliferation, viability, migration and invasion, and enhanced cell apoptosis and arrested cell cycle in G2 phase, and suppressed tumorigenicity of MGC-803 cells in mice. Furthermore, up-regulated expression of ZNF154 mRNA reduced the expression of B-cell lymphoma-2 (Bcl-2), matrix metalloproteinase 2 (MMP-1), hepatocyte growth factor (HGF), vascular endothelial growth factor-A/C (VEGF-A/C). Conclusion: ZNF154 inhibited LN metastasis of GC cells by suppressing several biological events of GC cells. ZNF154 was a tumor suppressor gene that is a promising target for blocking nodal involvement in GC.

15 December 2025 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
QZQing-Yun Zhao
Qing-Yun Zhao
SWShoujiang Wei
Shoujiang Wei
BACKGROUND Multiple exosomal microRNAs were reported to have a significant role in colorectal cancer (CRC) cells. The function and mechanism of exosomal miR-191 in CRC have not been clearly elucidated. AIM To explore the roles of miR-191 in CRC. METHODS Supernatant exosomes from CRC cells were extracted and identified. After coculture, macrophage polarization was determined using flow cytometry for the markers cluster of differentiation (CD) 68 and CD163, enzyme-linked immunosorbent assay for the cytokines interleukin (IL)-4 and IL-10, western blotting for chitinase-like protein 3 and arginase-1 expression, and immunofluorescent staining for 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate. Reactive oxygen species (ROS) level, ferroptosis-related proteins (SLC7A11 and GPX4 ), and apoptosis were determined with flow cytometry, western blotting, and TUNEL staining. We performed in vivo experiments to determine the function of exosomal miR-191 and M2 macrophage polarization. RESULTS We successfully isolated exosomes from CRC cells. Inhibition of miR-191 in CRC cells suppressed M2 polarization of macrophages. After coculture of macrophages, inhibition of miR-191 induced ROS production, ferroptosis, and apoptosis of CRC cells. Silencing of exosomal miR-191 from CRC cells prevented M2 polarization of macrophages, and weakened CRC development by inducing ferroptosis. Exosomal miR-191 accelerated cancer progression in CRC nude mice by promoting M2 polarization of macrophages. CONCLUSION Inhibition of exosomal miR-191 attenuated CRC progression by inducing ferroptosis in macrophages. This study revealed a novel mechanism by which exosomal miR-191 modulates the tumor microenvironment.

28 June 2025 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
WLWei Li
Wei Li
ZCZhi-Hong Chen
Zhi-Hong Chen
JYJun-Song Yang
Jun-Song Yang
JLJun-Yi Li
Jun-Yi Li
RLRui-Jie Lin
Rui-Jie Lin
SWShoujiang Wei
Shoujiang Wei

1 January 2026 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
JTJin Tang
Jin Tang
JYJing Yang
Jing Yang
JYJunsong Yang
Junsong Yang
SWShoujiang Wei
Shoujiang Wei
Background: Enhancing clinical thinking and competence is central to gastrointestinal surgical training. This study is aimed at evaluating the effectiveness of an integrated instructional model combining lecture‐based learning (LBL), problem‐based learning (PBL), and case‐based learning (CBL) in gastrointestinal surgical training. Methods: This prospective randomized controlled trial was conducted at the Affiliated Hospital of North Sichuan Medical College, China, from September to November 2024. A total of 120 gastrointestinal surgical trainees, including final‐year medical interns and first‐year surgical residents, were randomly assigned (1:1:1) to the LBL, PBL + CBL, or integrated LBL + PBL + CBL groups using a computer‐generated sequence, with allocation concealed by an independent assistant. After completing an 8‐week standardized curriculum delivered by the same teaching team, the following outcomes were assessed: critical thinking ability using the Chinese version of the California critical thinking disposition inventory (CTDI‐CV); theoretical knowledge through written and oral examinations; learning efficiency (study time and task completion rate) and satisfaction; and clinical competence assessed via the miniclinical evaluation exercise (Mini‐CEX). Data were analyzed using IBM SPSS Statistics with one‐way analysis of variance, and statistical significance was set at p < 0.05. Results: The integrated LBL + PBL + CBL groups achieved the highest CTDI‐CV total scores, theoretical knowledge performance, and Mini‐CEX scores compared with the other groups ( p < 0.05). Despite reporting the shortest weekly study time, the integrated group attained the highest task completion rate and learner satisfaction score ( p < 0.05). Conclusion: The integrated LBL + PBL + CBL approach enhances efficiency and is well‐suited for advancing clinical competence in surgical training. Trial registration: Chinese Clinical Trial Registry (ChiCTR2000041569).

9 January 2023 in Journal of Minimal Access Surgery
Verified
Journal Article
Open access
JLJianxiong Lai
Jianxiong Lai
PYPengcheng Ye
Pengcheng Ye
JYJunsong Yang
Junsong Yang
YFYanchao Feng
Yanchao Feng
KQKai Qiu
Kai Qiu
SWShoujiang Wei
Shoujiang Wei
Aims: The study was performed to verify the results of single-incision laparoscopic surgery (SILS) through the ileostomy site for low rectal cancer compared with conventional laparoscopic surgery (CLS). Materials and Methods: From January 2019 to November 2021, 133 patients with low rectal cancer underwent single-incision (n = 27) or conventional (n = 106) methods of low anterior rectal resection surgery with ileostomy. All patients were balanced by propensity score matching for basic information in a ratio of 1:2, resulting in 27 and 54 in SILS and CLS groups, respectively. Results: Relative to the CLS group, the SILS group exhibited fewer leucocyte changes, shorter time to first exhaust and first bowel sounds, shorter length of hospital stay and lower Visual Analogue Score on post-operative days (POD2) and POD3. Intraoperative or post-operative complications or readmissions were comparable between the two groups. The oncologic results remained consistent between the two groups other than the number of lymph nodes dissected in group no. 253. Conclusions: Single-incision laparoscopic low rectal resection surgery through the ileostomy site has advantages in terms of reduced post-operative pain, shorter post-operative exhaust time and length of hospital stay while also achieving oncologic outcomes similar to those of conventional laparoscopy. It can be an alternative procedure for patients with low rectal cancer who require ileostomy.